Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01178 (
oxytocin
)
15,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Understanding the neural components modulating feeding-related behavior and energy expenditure is crucial to combating obesity and its comorbidities. Neurons within the paraventricular nucleus of the hypothalamus (PVH) are a key component of the satiety response; activation of the PVH decreases feeding and increases energy expenditure, thereby promoting negative energy balance. In contrast, PVH ablation or silencing in both rodents and humans leads to substantial obesity. Recent studies have identified genetically-defined PVH subpopulations that control discrete aspects of energy balance (e.g.
oxytocin
(
OXT
), neuronal nitric oxide synthase 1 (
NOS1
), melanocortin 4-receptor (MC4R), prodynorphin (PDYN)). We previously demonstrated that non-
OXT
NOS1
PVH
neurons contribute to PVH-mediated feeding suppression. Here, we identify and characterize a non-
OXT
, non-
NOS1
subpopulation of PVH and peri-PVH neurons expressing insulin-receptor substrate 4 (IRS4
PVH
) involved in energy balance control. Using Cre-dependent viral tools to activate, trace and silence these neurons, we highlight the sufficiency and necessity of IRS4
PVH
neurons in normal feeding and energy expenditure regulation. Furthermore, we demonstrate that IRS4
PVH
neurons lie within a complex hypothalamic circuitry that engages distinct hindbrain regions and is innervated by discrete upstream hypothalamic sites. Overall, we reveal a requisite role for IRS4
PVH
neurons in PVH-mediated energy balance which raises the possibility of developing novel approaches targeting IRS4
PVH
neurons for anti-obesity therapies.
...
PMID:Paraventricular, subparaventricular and periventricular hypothalamic IRS4-expressing neurons are required for normal energy balance. 3221 85
